355 related articles for article (PubMed ID: 21481088)
1. Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
Yilmaz M; Isaoglu U; Delibas IB; Kadanali S
J Obstet Gynaecol Res; 2011 Aug; 37(8):1020-6. PubMed ID: 21481088
[TBL] [Abstract][Full Text] [Related]
2. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women.
Chae SJ; Kim JJ; Choi YM; Hwang KR; Jee BC; Ku SY; Suh CS; Kim SH; Kim JG; Moon SY
Hum Reprod; 2008 Aug; 23(8):1924-31. PubMed ID: 18579512
[TBL] [Abstract][Full Text] [Related]
3. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population.
Pehlivanov B; Orbetzova M
Gynecol Endocrinol; 2007 Oct; 23(10):604-9. PubMed ID: 17852429
[TBL] [Abstract][Full Text] [Related]
5. [Clinical, hormonal and metabolic characteristics of different phenotypes of polycystic ovary syndrome, in Bulgarian population].
Kavardzhikova S; Pechlivanov B
Akush Ginekol (Sofiia); 2010; 49(4):32-7. PubMed ID: 20734639
[TBL] [Abstract][Full Text] [Related]
6. Oligoanovulation with polycystic ovaries but not overt hyperandrogenism.
Dewailly D; Catteau-Jonard S; Reyss AC; Leroy M; Pigny P
J Clin Endocrinol Metab; 2006 Oct; 91(10):3922-7. PubMed ID: 16849400
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population.
Zhang HY; Zhu FF; Xiong J; Shi XB; Fu SX
BJOG; 2009 Nov; 116(12):1633-9. PubMed ID: 19781047
[TBL] [Abstract][Full Text] [Related]
8. Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria.
Shroff R; Syrop CH; Davis W; Van Voorhis BJ; Dokras A
Fertil Steril; 2007 Nov; 88(5):1389-95. PubMed ID: 17462641
[TBL] [Abstract][Full Text] [Related]
9. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
[TBL] [Abstract][Full Text] [Related]
10. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.
Panidis D; Tziomalos K; Misichronis G; Papadakis E; Betsas G; Katsikis I; Macut D
Hum Reprod; 2012 Feb; 27(2):541-9. PubMed ID: 22144419
[TBL] [Abstract][Full Text] [Related]
12. Psoriasis and polycystic ovary syndrome: a new link in different phenotypes.
Moro F; Tropea A; Scarinci E; Federico A; De Simone C; Caldarola G; Leoncini E; Boccia S; Lanzone A; Apa R
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():101-5. PubMed ID: 26115053
[TBL] [Abstract][Full Text] [Related]
13. Different phenotypes of polycystic ovary syndrome in Turkish women: clinical and endocrine characteristics.
Ates S; Sevket O; Sudolmus S; Dane B; Ozkal F; Uysal O; Dansuk R
Gynecol Endocrinol; 2013 Oct; 29(10):931-5. PubMed ID: 23998514
[TBL] [Abstract][Full Text] [Related]
14. Is hyperandrogenemia protective for fibrocystic breast disease in PCOS?
Ozkaya E; Cakir E; Cinar M; Kara F; Baser E; Cakir C; Kucukozkan T
Gynecol Endocrinol; 2012 Jun; 28(6):468-71. PubMed ID: 22103710
[TBL] [Abstract][Full Text] [Related]
15. Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study.
Hosseinpanah F; Barzin M; Keihani S; Ramezani Tehrani F; Azizi F
Clin Endocrinol (Oxf); 2014 Jul; 81(1):93-9. PubMed ID: 24428207
[TBL] [Abstract][Full Text] [Related]
16. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
Barber TM; Wass JA; McCarthy MI; Franks S
Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
[TBL] [Abstract][Full Text] [Related]
17. Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria.
Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
Arch Gynecol Obstet; 2016 Feb; 293(2):447-56. PubMed ID: 26408006
[TBL] [Abstract][Full Text] [Related]
18. Higher metabolic risk with National Institutes of Health versus Rotterdam diagnostic criteria for polycystic ovarian syndrome in Turkish women.
Anaforoglu I; Algun E; Incecayir O; Ersoy K
Metab Syndr Relat Disord; 2011 Oct; 9(5):375-80. PubMed ID: 21657888
[TBL] [Abstract][Full Text] [Related]
19. A 20-year follow-up of young women with polycystic ovary syndrome.
Carmina E; Campagna AM; Lobo RA
Obstet Gynecol; 2012 Feb; 119(2 Pt 1):263-9. PubMed ID: 22270277
[TBL] [Abstract][Full Text] [Related]
20. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors.
Broekmans FJ; Knauff EA; Valkenburg O; Laven JS; Eijkemans MJ; Fauser BC
BJOG; 2006 Oct; 113(10):1210-7. PubMed ID: 16972863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
